BSA
HOLX

Braun Stacey Associates’s Hologic HOLX Stock Holding History

Braun Stacey Associates’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,950
Closed -$215K – 139
2020
Q4 		$215K Buy
+2,950
New +$208K 0.01% 127
2015
Q3 		– Sell
-8,100
Closed -$308K – 199
2015
Q2 		$308K Buy
+8,100
New +$284K 0.01% 269

Other funds holding HOLX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Braun Stacey Associates's HOLX Position: Q1 2021 in Review

Braun Stacey Associates sold out of Hologic (HOLX) in Q1 2021, closing a stake of 2,950 shares — an estimated $215K sold.

Braun Stacey Associates first reported a position in HOLX in Q2 2015 and held it in 2 quarters. The position peaked at $308K in Q2 2015. 638 funds tracked by Wall St. Rank hold HOLX as of Q1 2021.

  • Braun Stacey Associates reported no remaining Hologic position as of Q1 2021 after selling out during the quarter.
  • Braun Stacey Associates sold 2,950 Hologic shares in Q1 2021, an estimated $215K.
  • Braun Stacey Associates first reported a position in Hologic in Q2 2015 and held it in 2 quarters.
  • Braun Stacey Associates's Hologic position peaked at $308K in Q2 2015.
  • 638 funds tracked by Wall St. Rank held Hologic as of Q1 2021.

Based on Braun Stacey Associates's 13F filing for Q1 2021, filed 28 Apr 2021.